venBio Global Strategic Fund III, L.P. Insider Profile
4 Followers
venBio Global Strategic Fund III, L.P., Ten Percent Owner at Elevation Oncology, holds 1.94M shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV), holds 5.16M shares in RayzeBio, Inc. (Ticker: RYZB), holds 1.91M shares in Elevation Oncology (Ticker: ELEV).
venBio Global Strategic Fund III, L.P. insider profile FAQ
What is the percentage of profitable transactions made by venBio Global Strategic Fund III, L.P.?
The percentage of profitable transactions made by venBio Global Strategic Fund III, L.P. is 33%.
What is the average return per transaction made by venBio Global Strategic Fund III, L.P.?
The average return per transaction made by venBio Global Strategic Fund III, L.P. is -30.70%.
What stocks does venBio Global Strategic Fund III, L.P. hold?
venBio Global Strategic Fund III, L.P. holds: ELEV, VTYX, RYZB, ARTV stocks.
What was venBio Global Strategic Fund III, L.P.’s latest transaction?
venBio Global Strategic Fund III, L.P. latest transaction was an Uninformative Buy of ―.
What was venBio Global Strategic Fund III, L.P.'s most profitable transaction?
venBio Global Strategic Fund III, L.P.’s most profitable transaction was an Informative Buy of VTYX stock on October 25, 2021. The return on the trade was 50.50%.
What is venBio Global Strategic Fund III, L.P.'s role in Elevation Oncology?
venBio Global Strategic Fund III, L.P.'s role in Elevation Oncology is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.